Refine by
Pulmonary Arterial Technology
2 companies found
Technologybased inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the ...
Technologybased inCaesarea Industrial Park (N), ISRAEL
V-WAVE was established in Israel in 2009 with a focus on developing percutaneous implantable technologies for patients with chronic heart failure. Technology designed by V-Wave, highlighted by its Ventura Interatrial Shunt System, was designed to ...
Heart failure (HF) is a condition where the heart is not pumping enough blood to meet the needs of the body. When heart failure occurs, there is an increase in pressure in the heart and lungs, plus fluid build-up in the lungs. The fluid causes ...